These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1793785)

  • 1. Helicobacter pylori: treatment with combinations of pivampicillin and tripotassium dicitrato bismuthate.
    Weil J; Bell GD; Powell K; Morden A; Harrison G; Gant PW; Trowell JE; Burridge S
    Aliment Pharmacol Ther; 1991 Oct; 5(5):543-7. PubMed ID: 1793785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication?
    Bell GD; Powell K; Burridge SM; Harrison G; Weil J; Gant PW; Jones PH; Trowell JE
    Aliment Pharmacol Ther; 1992 Jun; 6(3):327-33. PubMed ID: 1600049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.
    Xiao SD; Liu WZ; Hu PJ; Xia DH; Tytgat GN
    Aliment Pharmacol Ther; 1999 Mar; 13(3):311-5. PubMed ID: 10102963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination.
    Weil J; Bell GD; Powell K; Morden A; Harrison G; Gant PW; Jones PH; Trowell JE
    Aliment Pharmacol Ther; 1990 Dec; 4(6):651-7. PubMed ID: 2129652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidine.
    Liu WZ; Xiao SD; Hu PJ; Lu H; Cui Y; Tytgat GN
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1519-22. PubMed ID: 11069324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-week eradication regimen for metronidazole-resistant Helicobacter pylori.
    Logan RP; Gummett PA; Misiewicz JJ; Karim QN; Walker MM; Baron JH
    Aliment Pharmacol Ther; 1993 Apr; 7(2):149-53. PubMed ID: 8485267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice.
    Vautier G; Scott BB
    Aliment Pharmacol Ther; 1997 Feb; 11(1):107-8. PubMed ID: 9042981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of therapeutic regimens for the treatment of Helicobacter pylori infection.
    Lee DH; Park HJ; Song SY; Lee SJ; Choi W; Lee YC; Chung JB; Kang JK; Park IS; Lee YH; Kim HK
    Yonsei Med J; 1996 Aug; 37(4):270-7. PubMed ID: 8942297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short report: short-term triple therapy for H. pylori-associated duodenal ulcer disease.
    Patchett S; Beattie S; Keane C; O'Morain C
    Aliment Pharmacol Ther; 1992 Feb; 6(1):113-7. PubMed ID: 1543813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I; Worsley BW; O'Connor HJ; Axon AT
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection.
    Thijs JC; Van Zwet AA; Moolenaar W; Oom JA; De Korte H; Runhaar EA
    Aliment Pharmacol Ther; 1994 Feb; 8(1):131-4. PubMed ID: 8186339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One week eradication regimen for Helicobacter pylori.
    Logan RP; Gummett PA; Misiewicz JJ; Karim QN; Walker MM; Baron JH
    Lancet; 1991 Nov; 338(8777):1249-52. PubMed ID: 1682653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori.
    Bell GD; Powell KU; Burridge SM; Spencer G; Bolton G; Purser K; Brooks S; Prosser S; Harrison G; Gant PW
    Aliment Pharmacol Ther; 1992 Dec; 6(6):751-8. PubMed ID: 1486161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up.
    Archimandritis A; Balatsos V; Delis V; Mentis A; Kastanas K; Scandalis N
    J Clin Gastroenterol; 1995 Jan; 20(1):12-6. PubMed ID: 7884169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.
    Bell GD; Powell K; Burridge SM; Pallecaros A; Jones PH; Gant PW; Harrison G; Trowell JE
    Aliment Pharmacol Ther; 1992 Aug; 6(4):427-35. PubMed ID: 1420735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tripotassium dicitrato bismuthate on the rat stomach.
    Waldum HL; Qvigstad G; Mårvik R; Brenna E; Syversen U; Sandvik AK
    Aliment Pharmacol Ther; 1994 Aug; 8(4):425-31. PubMed ID: 7527257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One week treatment for Helicobacter pylori infection: a randomised study of quadruple therapy versus triple therapy.
    Phull PS; Griffiths AE; Halliday D; Jacyna MR
    J Antimicrob Chemother; 1995 Dec; 36(6):1085-8. PubMed ID: 8821611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early results of treating Helicobacter pylori infections in patients with gastric ulcer and gastritis].
    Jarczyk G; Jarczyk J; Raczyńska A; Jedrzejczyk W
    Pol Merkur Lekarski; 1996 Sep; 1(3):174-8. PubMed ID: 9139781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripotassium dicitrato bismuthate: absorption and urinary excretion of bismuth in patients with normal and impaired renal function.
    Treiber G; Gladziwa U; Ittel TH; Walker S; Schweinsberg F; Klotz U
    Aliment Pharmacol Ther; 1991 Oct; 5(5):491-502. PubMed ID: 1793780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.